BCWM
RMD icon

Bartlett & Co Wealth Management’s ResMed RMD Stock Holding History

Bartlett & Co Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419 Sell
2
-23
-92% -$5.73K ﹤0.01% 1176
2025
Q4 		$6.02K Buy
25
+13
+108% +$3.33K ﹤0.01% 989
2025
Q3 		$3.29K Buy
12
+11
+1,100% +$3K ﹤0.01% 1051
2025
Q2 		$258 Hold
1
– – ﹤0.01% 1187
2025
Q1 		$224 Buy
+1
New +$233 ﹤0.01% 1162

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bartlett & Co Wealth Management's RMD Position: Q1 2026 in Review

Bartlett & Co Wealth Management reduced its ResMed (RMD) stake by 92% in Q1 2026, selling an estimated $5.73K and leaving 2 shares worth $419. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Bartlett & Co Wealth Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.02K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Bartlett & Co Wealth Management held 2 shares of ResMed worth $419 as of Q1 2026.
  • Bartlett & Co Wealth Management sold 23 ResMed shares in Q1 2026, an estimated $5.73K.
  • ResMed made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #1176 holding.
  • Bartlett & Co Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • Bartlett & Co Wealth Management's ResMed position peaked at $6.02K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.